Free Trial

STERIS plc (NYSE:STE) Holdings Lessened by Diker Management LLC

STERIS logo with Medical background

Diker Management LLC reduced its stake in shares of STERIS plc (NYSE:STE - Free Report) by 0.4% in the fourth quarter, according to its most recent filing with the Securities & Exchange Commission. The firm owned 265,233 shares of the medical equipment provider's stock after selling 1,133 shares during the period. STERIS comprises 47.3% of Diker Management LLC's investment portfolio, making the stock its biggest position. Diker Management LLC owned approximately 0.27% of STERIS worth $54,521,000 as of its most recent filing with the Securities & Exchange Commission.

Several other large investors also recently modified their holdings of the stock. Avalon Trust Co bought a new position in STERIS in the 4th quarter worth approximately $30,000. Human Investing LLC purchased a new position in STERIS in the 4th quarter worth approximately $31,000. Anfield Capital Management LLC raised its stake in shares of STERIS by 100.0% during the fourth quarter. Anfield Capital Management LLC now owns 182 shares of the medical equipment provider's stock valued at $37,000 after acquiring an additional 91 shares during the last quarter. Manchester Capital Management LLC lifted its stake in STERIS by 182.7% in the fourth quarter. Manchester Capital Management LLC now owns 212 shares of the medical equipment provider's stock worth $44,000 after acquiring an additional 137 shares during the period. Finally, Brown Brothers Harriman & Co. boosted its position in STERIS by 66.7% during the 4th quarter. Brown Brothers Harriman & Co. now owns 220 shares of the medical equipment provider's stock valued at $45,000 after acquiring an additional 88 shares in the last quarter. Hedge funds and other institutional investors own 94.69% of the company's stock.

Analysts Set New Price Targets

Several research analysts recently issued reports on the stock. Stephens upgraded shares of STERIS to a "strong-buy" rating in a research note on Thursday, May 1st. Needham & Company LLC reiterated a "hold" rating on shares of STERIS in a report on Monday, April 7th. JMP Securities restated a "market outperform" rating and issued a $265.00 price target on shares of STERIS in a research note on Thursday, April 10th. Finally, Piper Sandler lifted their price objective on STERIS from $260.00 to $265.00 and gave the company an "overweight" rating in a research note on Monday, February 3rd. One analyst has rated the stock with a hold rating, four have issued a buy rating and one has assigned a strong buy rating to the company. According to data from MarketBeat.com, the stock presently has an average rating of "Buy" and a consensus target price of $258.75.

Check Out Our Latest Research Report on STERIS

STERIS Stock Up 0.3 %

STE stock traded up $0.68 during midday trading on Friday, hitting $226.54. The company's stock had a trading volume of 511,899 shares, compared to its average volume of 536,534. The company has a market cap of $22.26 billion, a PE ratio of 48.10 and a beta of 0.96. The firm's 50-day moving average is $223.40 and its 200-day moving average is $218.85. STERIS plc has a 12 month low of $200.98 and a 12 month high of $248.24. The company has a current ratio of 2.13, a quick ratio of 1.40 and a debt-to-equity ratio of 0.32.

STERIS (NYSE:STE - Get Free Report) last posted its earnings results on Wednesday, February 5th. The medical equipment provider reported $2.32 earnings per share (EPS) for the quarter, missing the consensus estimate of $2.33 by ($0.01). STERIS had a net margin of 8.66% and a return on equity of 13.91%. On average, equities research analysts forecast that STERIS plc will post 9.08 earnings per share for the current fiscal year.

STERIS Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Thursday, June 26th. Investors of record on Tuesday, June 10th will be issued a $0.57 dividend. This represents a $2.28 annualized dividend and a yield of 1.01%. The ex-dividend date of this dividend is Tuesday, June 10th. STERIS's dividend payout ratio is currently 48.41%.

STERIS Company Profile

(Free Report)

STERIS plc provides infection prevention products and services worldwide. It operates through four segments: Healthcare, Applied Sterilization Technologies, Life Sciences, and Dental. The Healthcare segment offers cleaning chemistries and sterility assurance products; automated endoscope reprocessing system and tracking products; endoscopy accessories, washers, sterilizers, and other pieces of capital equipment for the operation of a sterile processing department; and equipment used directly in the operating room, including surgical tables, lights, and connectivity solutions, as well as equipment management services.

Featured Articles

Institutional Ownership by Quarter for STERIS (NYSE:STE)

Should You Invest $1,000 in STERIS Right Now?

Before you consider STERIS, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and STERIS wasn't on the list.

While STERIS currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Reduce the Risk Cover

Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Enter your email address to learn more about using beta to protect your portfolio.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

5 Blowout Earnings Winners That Could Soar Even Higher
5 Stocks You’ve Never Heard Of That I’m Buying Nonstop in 2025
3 Sectors With Massive Momentum You Can’t Afford to Miss

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines